SEC Form 4Coverage since Jul 23, 2026
$IRD insider trading
Over the last 12 months, Opus Genetics insiders reported no purchases and 4 sales totaling $87K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $87K 4 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 4 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $IRD · 12Mvia TradingView
Top insiders · 12m
SCHACHLE JOSEPH KChief Operating Officer1× · $14K
YERXA BENJAMIN RPresident1× · $22K
Gagnon Robert E.Chief Financial Officer1× · $23K
Magrath GeorgeChief Executive Officer1× · $28K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | YERXA BENJAMIN RPresident · O·D | ▼ Sale | 7,429 | $2.97 | $22K | -1% | — |
| Jul 23, 2026 | SCHACHLE JOSEPH KChief Operating Officer · O | ▼ Sale | 4,644 | $2.94 | $14K | -1.6% | — |
| Jul 23, 2026 | Magrath GeorgeChief Executive Officer · O·D | ▼ Sale | 9,475 | $2.95 | $28K | -0.5% | — |
| Jul 23, 2026 | Gagnon Robert E.Chief Financial Officer · O | ▼ Sale | 7,783 | $2.95 | $23K | -1.3% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $IRD feed.